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Aqueous Recognition of Purine and Pyrimidine Bases by an 
Anthracene‒Based Macrocyclic Receptor 
Danny Van Eker, Soumen K. Samanta, Anthony P. Davis,*
 
A water-soluble bis-anthracenyl tetralactam binds biogenic 
heterocycles with high affinities in aqueous solution, rising to 107 
M-1 for the purine hypoxanthine.  Recognition occurs through a 
combination of hydrogen bonding and hydrophobic interactions, 
and results in fluorescence changes which suggest applications in 
sensing. 
 
Controlling molecular recognition in water is a key objective of 
supramolecular chemistry.1  Water is the solvent of life, so by 
far the most relevant for biological and medical applications.  
Moreover its effects are complex, depressing polar 
interactions (e.g. hydrogen bonding) through solvation of 
binding groups yet driving association through hydrophobic 
interactions between apolar surfaces.  The recognition of polar 
organic molecules in water is especially challenging, as both 
factors come into play.  From biology we can learn that high 
affinities are possible if both H-bonding and hydrophobic 
moieties are properly deployed (sometimes very high, as in the 
case of the avidin-biotin pairing2).  However, there are still 
relatively few synthetic receptors where both types of 
interaction are preorganised to achieve molecular recognition 
in water.3 
 Among substrates of biological interest, there are many 
that include purine or pyrimidine base units.  These structures 
have been addressed previously with some success, mostly 
through the application of hydrophobic interactions 
supplemented by electrostatic attraction in the case of 
charged substrates (ATP, nucleic acids etc.).4,5  Hydrogen 
bonding has not generally been exploited, presumably because 
it is considered ineffective in aqueous media.  For uncharged 
substrates, affinities have generally been in the range 103 - 105 
M-1.5  We now report that the bis-anthracenyl tetralactam 1 
(Fig. 1), with inward-directed NH groups, serves as a receptor 
for several of these heterocycles in water.  The receptor is 
notably selective, favouring the important biomarker 
hypoxanthine 3 which is bound with Ka ~107 M-1.  1H NMR and 
modelling studies suggest that hydrogen bonding contributes 
to this unusually high affinity, illustrating the potential for 
combining polar and apolar interactions to achieve molecular 
recognition in water. 
 Receptor 1 belongs to a family of tetralactams, with 
identical core structures but different solubilising groups, 
which were originally designed to bind glucose in sandwich-
type complexes.6,7  Glucose was indeed bound with Ka = 60-90 
M-1 in water, and the complex geometry was confirmed using 
X-ray crystallography.8  Moreover the anthracene fluorescence 
was enhanced on binding, suggesting the potential for glucose 
sensing.  Unfortunately, the sensitivity to glucose was lost 
when the system was transferred to blood serum, and this 
raised the possibility that other biogenic small molecules might 
bind to the cavity.   
 Considering the likely interferents that could be present, 
polar aromatic compounds seemed good candidates.  
Modelling suggests that the anthracene planes in 1 are ~7.3 Å 
apart.  This spacing is approximately twice the inter-base 
distance in DNA, so almost ideal for an aromatic guest9 (and 
slightly too small for glucose10).  Purines and pyrimidines 
possess lone pairs in the plane of the aromatic ring, with 
potential for H-bonding to receptor NH, so could be good 
substrates for 1.11   
 Uric acid 2 is present in serum at relatively high levels 
(typically ~0.3 mM) and seemed a likely possibility.  Indeed, 
both 1H NMR and fluorescence titrations gave evidence that 1 
binds 2 quite strongly.  Titration of uric acid into 1 in D2O (10 
mM phosphate buffer, pH 7.4) caused broadening of the 
receptor 1H NMR signals and the appearance of new peaks, 
saturating at ~1.6 equivalents (Fig. S20).  The fluorescence 
emission of 1 in H2O (buffered similarly) was reduced by 
addition of 2, as shown in Fig. 2.  The NMR data could not be 
quantified due to signal broadening, but the fluorescence 
output fit well to a 1:1 binding model with Ka = 1.7  105 M-1 
(Fig 2).  Isothermal titration calorimetry (ITC) yielded a similar 
value of 1.8  105 M-1. 
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 The above results confirmed that uric acid 2 was a good 
candidate for the interfering species in blood serum, but also 
suggested that other purines and/or pyrimidines could be 
substrates for 1.  We therefore tested the binding of 1 to eight 
further biogenic heterocycles (3-10; see Fig. 1).  The results are 
summarised in Table 1.  Trianionic ATP 10 was only bound very 
weakly, but all the neutral substrates were bound with Ka = 2  
103 M-1 or greater.  Most notably, the titration of hypoxanthine 
3 into receptor 1 caused an increase in fluorescence which was 
analysed to give Ka = 8.7  106 M-1, ≥ 15 times higher than for 
other substrates (Fig. 3).  Again this result was supported by 
ITC, which gave Ka = 8.1 x 106 M-1.  1H NMR titrations showed 
changes consistent with binding (Fig S22; see discussion 
below) but quantification was again prevented by signal 
broadening.  Hypoxanthine is the metabolic product of ATP 
under oxygen-deficiency, and an important biomarker for 
conditions like acute cardiac ischemia, prostate cancer and 
neonatal hypoxia.12  It is also of interest as an indicator of 
ageing in meat and fish.13 
 
Table 1. Association constants measured for receptor 1 to heterocyclic guests in 
aqueous solution.a 
Guests Ka [M-1] 
Uric Acid 2 1.7 × 105, 1.8 × 105 b 
Hypoxanthine 3 8.7 × 106, 8.1× 106 b 
Caffeine 4 1.7 × 105, 1.6 × 105 b 
Theobromine 5 1.1 × 105 
Adenine 6 1.3 × 105 
Thymine 7 5.8 × 105 c 
Uracil 8 9.1 × 103 c 
Cytosine 9 2.3 × 103 
ATP 10 24 
a Measured by fluorescence titration in aqueous phosphate buffer (10 mM, pH 
7.4) at 298 K, unless otherwise indicated.  All data were fitted to a 1:1 binding 
model.  b Measured by ITC in aqueous phosphate buffer (10 mM, pH 7.4) at 298 K.  
c  Measured by 1H NMR titration in D2O (10 mM phosphate buffer, pH 7.4) at 298 
K.  These substrates are thought to be capable of 1:2 binding, so the listed 1:1 Ka 
values are considered “apparent”. 
 
 
Fig. 1  Receptor 1 and the purine and pyrimidine substrates used in this work.  Uric acid 2 is represented as the monoanion. 
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Fig. 2   Top: Fluorescence titration of receptor 1 (11.8 µM) with uric acid 2 in 10 
mM phosphate buffer, pH 7.4.  F = fluorescence emission intensity.  Bottom: Plot 
of experimental data (dots) and calculated values (line) from 1:1 binding analysis 
using Bindfit software.  Emission observed at 427 nm.  Ka = 1.7×105 M-1 ± 1.2% 
Journal Name  COMMUNICATION 
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 3  
Please do not adjust margins 
Please do not adjust margins 
 
 Of the other substrates, the purine alkaloids caffeine 4 and 
theobromine 5 also increased fluorescence emission, 
consistent with Ka = 1.7  105 M-1 and 1.1  105 M-1 
respectively.  Interestingly, theobromine 5 caused a 
remarkable 15-fold enhancement (Fig S8), much higher than 
the ~3-fold increase for caffeine or hypoxanthine.  The affinity 
of 1 for caffeine was confirmed by ITC; a1H NMR titration again 
gave broadened peaks.  Adenine 6 caused the fluorescence 
spectrum to shift with a small decrease in intensity, analysed 
to give Ka = 1.3  105 M-1.  The behaviour of the pyrimidines, 
thymine and uracil was more complex.  In fluorescence 
titrations the curves showed sigmoidal shapes, consistent with 
strong 1:1 binding causing minimal changes in emission 
followed by 1:2 complex formation causing substantial 
increases (Figs S13 and S15).  These substrates were also 
studied using 1H NMR titrations for which, unlike 2-4, signals 
remained sharp but moved as expected for binding with fast 
exchange.  Here, the changes fitted well to a 1:1 binding model 
consistent with Ka = 5.8  105 M-1 for thymine 7 and 9.1 × 103 
M-1 for uracil 8.  Given the evidence for 1:2 binding, which 
could affect the analyses, these values should be considered 
“apparent”.  Finally, cytosine 9 gave small fluorescence 
changes analysed to give Ka = 2.3  103 M-1. 
 
 The structures of the complexes were studied using 1H 
NMR and molecular modelling.  Of particular interest was the 
role of hydrogen bonding in promoting binding, especially to 
hypoxanthine 3.  The NMR titration for 1 + 3 was repeated in 
H2O/D2O 9:1, so that signals due to NH could be followed.14  
Although broadening complicated the interpretation, signals at 
8.75 and 9.25 p.p.m. could be assigned to the lactam NH in 
receptor and complex respectively.  The 0.5 p.p.m. downfield 
shift suggests significant NH···X hydrogen bonding in the 
complex, given the extensive NH solvation in the free receptor.  
The movement is twice as large as that observed earlier for 1 + 
methyl β-D-glucoside in water.6 
 Modelling of the complexes between 1 and purines 2-6 
was performed using Monte Carlo Molecular Mechanics 
(MCMM), allowing the guests to move within the cavity before 
each minimisation.  All calculations yielded structures with 
four intermolecular NH···N or NH···O hydrogen bonds in the 
range ~2.0-2.2 Å.  The ground state structure for the 
hypoxanthine complex 1ˑ3 is shown in Figure 4.  Overlap 
between the host and guest aromatic surfaces is excellent, 
although this is also true of the urate and adenine complexes 
1ˑ2 and 1ˑ6 (by contrast, caffeine and theobromine protrude 
slightly from the cavity, see Figs. S35 and S36).  The preference 
for hypoxanthine presumably results from subtle differences in 
guest geometry and solvation.  Of the pyrimidine guests, 
thymine 7 and uracil 8 were modelled binding to 1 in 2:1 
stoichiometry.  Both these guests can form H-bonded dimers.  
Insertion into the cavity of 1 followed by energy minimisation 
gives plausible structures held together by six intermolecular 
hydrogen bonds.  The complex between 1 and the uracil dimer 
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Fig. 3   Top: Fluorescence titration of receptor 1 (550 nM) with hypoxanthine 3 in 
10 mM phosphate buffer, pH 7.4.  F = fluorescence emission intensity.  Bottom: 
Plot of experimental data (dots) and calculated values (line) from 1:1 binding 
analysis using Bindfit software.  Emission observed at 427 nm.  Ka = 8.7×106 M-1 ± 
2.5%. 
 
 
 
Fig. 4   Top: Model of hypoxanthine 3 bound to receptor 1.  Side-chains are 
omitted for clarity.  Intermolecular hydrogen bonds are shown as yellow dashed 
lines.  Side-chains are omitted for clarity.  Bottom: Model of uracil 8 dimer bound 
to receptor 1.  For details of calculations see supporting information. 
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is shown in Figure 4.  Finally, an MCMM calculation on the 
cytosine complex 1ˑ9 gave a structure with just two 
intermolecular H-bonds, consistent with the relatively low 
binding constant. 
 In conclusion we have shown that while macrocycle 1 is a 
moderate receptor for glucose, it is highly effective for several 
biogenic heterocycles.  Affinities rise to 107 M-1 for the optimal 
substrate hypoxanthine 3, unusually high for a synthetic 
receptor binding a biologically relevant, neutral polar molecule 
in water.  While this discovery limits the potential of 1 as a 
glucose sensor, the selectivity for 3 and fluorescence response 
raises the possibility of hypoxanthine sensing, with 
applications in medicine and food safety.  Meanwhile, more 
generally, the results provide further evidence that hydrogen 
bonding and hydrophobic interactions can combine to achieve 
strong and selective binding in water. 
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